| Literature DB >> 34221076 |
Maryam Mohseni1, Mohammad Eghbali2,3, Homa Bahrami4, Farzaneh Dastaran5, Leila Amini6,7.
Abstract
The aim of this study was to investigate the effects of yoga exercises on anthropometric parameter and clinical sign of PCOS among women undergoing infertility treatment. This clinical trial study was performed on 61 women with PCOS who have undergone infertility treatment at Sarem Hospital in Tehran, Iran. The patients were first selecting based on purposeful and then randomly assigning to the intervention and control groups. In the intervention group, yoga exercises were performed for 6 weeks and the patients in the control group only received routine care. Anthropometric parameters and clinical signs were performed and recorded. After the intervention, here was a significant reduction in hirsutism, abdominal circumference, and hip circumference scores in the intervention group compared to the control group (P < 0.05). Given the effects of yoga exercises on the improvement of hirsutism, abdominal circumference, and hip circumference, it is suggested to use yoga as a treatment strategy in women with PCOS.Entities:
Year: 2021 PMID: 34221076 PMCID: PMC8213483 DOI: 10.1155/2021/5564824
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Images of the different asana positions in yoga session for 45 minutes: (a) makarasana; (b) bhujangasana; (c) dharmikasana; (d) paschimottanasana; (e) sardulasana; (f) bhadrasana; (g) matsyedrasana; (h) savasana according to [23–25].
Figure 2Study design flow diagram.
Sociodemographic and menstrual cycle characteristic of all patients.
| Variable | Intervention group ( | Control group ( |
|
|---|---|---|---|
| Age | 30.77 ± 6.01 | 30.35 ± 5.53 | 0.782 |
| Level of education | |||
| Middle school | 4 (13.3%) | 7 (22.6%) | 0.358 |
| Diploma | 9 (30%) | 5 (16.1%) | |
| University | 17 (56.7%) | 19 (61.3%) | |
| Occupation | |||
| Housewife | 19 (63.3%) | 16 (51.6%) | 0.355 |
| Employee | 11 (36.7%) | 15 (48.4%) | |
| Economic status | |||
| Desirable | 9 (30%) | 10 (32.3%) | 0.999 |
| Partly desirable | 20 (66.7%) | 20 (64.5%) | |
| Undesirable | 1 (3.3%) | 1 (3.2%) | |
| Insurance status | |||
| Yes | 28 (93.3%) | 28 (90.3%) | 0.999 |
| No | 2 (6.7%) | 3 (9.7%) | |
| Menstrual pain | |||
| Mild | 10 (33.3%) | 15 (48.4%) | 0.169 |
| Moderate | 17 (56.7%) | 16 (51.6%) | |
| Severe | 3 (10%) | 0 | |
| Age at the first menstruation (years) | 13 ± 1.53 | 12.9 ± 1.72 | 0.817 |
| Duration of each cycle (days) | 31.77 ± 5.38 | 31.13 ± 5.69 | 0.655 |
| Duration of infertility (years) | 6.60 ± 2.71 | 6.97 ± 3.75 | 0.664 |
Independent t-test. Chi-square test. Fisher exact test.
Anthropometric parameter of PCO in the intervention group and control group.
| Intervention group, | Control group, |
| |
|---|---|---|---|
| Body mass index | |||
| Baseline | 25.96 (3.24) | 25.50 (3.50) | 0.597 |
| 6 weeks later | 25.32 (2.63) | 25.39 (3.50) | 0.929 |
| Abdominal circumference (cm) | |||
| Baseline | 93.83 (8.29) | 94.97 (7.61) | 0.580 |
| 6 weeks later | 87.23 (8.29) | 91.55 (8.18) | 0.045 |
| Hip circumference (cm) | |||
| Baseline | 102.97 (10.24) | 98.06 (6.26) |
|
| 6 weeks later | 95.80 (9.14) | 94.84 (8.38) | 0.027 |
| Systolic blood pressure (mmhg) | |||
| Baseline | 110.23 (10.33) | 110.26 (10.15) | 0.938 |
| 6 weeks later | 110.00 (10.26) | 110.29 (1.42) | 0.402 |
| Diastolic blood pressure (mmhg) | |||
| Baseline | 60.73 (10.34) | 70.26 (10.06) | 0.096 |
| 6 weeks later | 70.20 (0.89) | 70.48 (0.99) | 0.245 |
Independent t-test. ANCOVA.
Clinical sign of PCO in the intervention group and control group.
| Intervention group, | Control group, |
| |||
|---|---|---|---|---|---|
| Yes | No | Yes | No | ||
|
| |||||
| Baseline | 4 (13.3%) | 26 (86.7%) | 4 (12.9%) | 27 (87.1%) | 0.999 |
| 6 weeks later | 4 (13.3%) | 26 (86.7%) | 4 (12.9%) | 27 (87.1%) | 0.999 |
| Alopecia | |||||
| Baseline | 6 (20%) | 24 (80%) | 6 (19.4%) | 25 (87.1) | 0.949 |
| 6 weeks later | 6 (20%) | 24 (80%) | 6 (19.4%) | 25 (87.1) | 0.949 |
| Hirsutism (Ferriman–Gallwey) | |||||
| Baseline | 8.87 (3.19) | 10.19 (3.68) | 0.139 | ||
| 6 weeks later | 7.13 (2.14) | 9.9 (2.02) | 0.001 | ||
Fisher exact test. Chi-square test. Independent t-test.